ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135168; 2) Community: the network communities that were significantly associated with the response to NSC 135168; 3) Molecule: the relationships between components within communities and NSC 135168; 4) MDR: the compounds that were significantly associated with the NSC 135168.

NSC Compound Enrichment Correlation
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.0103070729572494 0.44863776
NSC 184692 Aminopterin Derivative 0.0103070729572494 0.38961519
NSC 207895 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0103070729572494 0.22810972
NSC 219733 N,N'-Bis(9-acridinyl)-1,6-hexanediamine 0.0103070729572494 0.23920084
NSC 244714 Benzoic acid, 3,5-dinitro-2-(1H-purin-6-ylthio)-, ethyl ester 0.0103070729572494 0.27569143
NSC 250682 Oridonin 0.0103070729572494 0.093823496
NSC 274548 Gold, [.mu.-[[5,5'-methylenebis[1H-tetrazolato]](2-)-N(1):N(1')]]bis(triphenylphosphine)di- 0.0103070729572494 0.13579003
NSC 282880 Ethanaminium, 2-[[hydroxy(octadecyloxy)phosphinyl]oxy]-N,N,N-trimethyl-, inner salt (9CI) 0.0103070729572494 0.21511224
NSC 3088 Chlorambucil 0.0103070729572494 0.1960464
NSC 314622 Indenoisoquinoline derivative 0.0103070729572494 0.25538569
Total:171  Current:57    [First] [Prev] [Next] [Last]